marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
ENDRA Life Sciences Balance Sheet 2011-2024 | NDRA
Annual Balance Sheet ENDRA Life Sciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-4.37 M | -8.78 M | -6.54 M | -5.47 M | -6.47 M | -5.6 M | 805 K | -19.1 K | -156 K | - | - | - | |
Long Term Debt |
- | 366 K | 547 K | 337 K | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
174 K | 152 K | 132 K | 76.5 K | 66.2 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
192 K | 366 K | - | 609 K | 343 K | - | - | - | 1 | - | - | - | - |
Total Current Liabilities |
903 K | 1.7 M | 1.54 M | 987 K | 2.07 M | 975 K | 848 K | - | - | - | - | - | - |
Total Liabilities |
1.1 M | 2.07 M | 2.09 M | 1.6 M | 2.42 M | 975 K | 848 K | 1.38 M | 236 K | 97.6 K | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-91.9 M | -81.9 M | -68.7 M | -57.3 M | -45.2 M | -27.7 M | -17.9 M | -12.5 M | -9.74 M | -7.46 M | - | - | - |
Total Assets |
6.75 M | 9.27 M | 12.9 M | 8.76 M | 7.18 M | 7.22 M | 6.12 M | 491 K | 487 K | 703 K | - | - | - |
Cash and Cash Equivalents |
2.83 M | 4.89 M | 9.46 M | 7.23 M | 6.17 M | 6.47 M | 5.6 M | 145 K | - | - | - | - | - |
Book Value |
5.66 M | 7.2 M | 10.8 M | 7.17 M | 4.76 M | 6.25 M | 5.28 M | -894 K | 250 K | 605 K | - | - | - |
Total Shareholders Equity |
5.66 M | 7.2 M | 10.8 M | 7.17 M | 4.76 M | 6.25 M | 5.28 M | -894 K | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet ENDRA Life Sciences
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
98.4 K | - | 192 K | 237 K | 281 K | 324 K | 366 K | 434 K | 473 K | 510 K | 547 K | 553 K | 586 K | 252 K | 272 K | 290 K | 272 K | 272 K | 343 K | 343 K | 343 K | 343 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
98.4 K | 146 K | 192 K | 237 K | - | - | 366 K | - | - | - | - | - | - | 281 K | 609 K | 628 K | 645 K | 326 K | 343 K | 343 K | 343 K | 343 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.45 M | 1.36 M | 1.1 M | 2.41 M | 2.31 M | 2.16 M | 2.07 M | 2.14 M | 1.98 M | 1.87 M | 2.09 M | 2.16 M | 2.25 M | 1.05 M | 1.6 M | 2.03 M | 1.6 M | 1.6 M | 2.42 M | 2.42 M | 2.42 M | 2.42 M | 975 K | 975 K | 975 K | 975 K | 848 K | 848 K | 848 K | 848 K | 1.38 M | 1.38 M | 1.38 M | 1.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-96.9 M | -94.7 M | -91.9 M | -90.5 M | -87.4 M | -84.8 M | -81.9 M | -78.6 M | -75.1 M | -71.5 M | -68.7 M | -65.6 M | -62.9 M | -59.7 M | -57.3 M | -55.1 M | -57.3 M | -57.3 M | -45.2 M | -45.2 M | -45.2 M | -45.2 M | -27.7 M | -27.7 M | -27.7 M | -27.7 M | -17.9 M | -17.9 M | -17.9 M | -17.9 M | -12.5 M | -12.5 M | -12.5 M | -12.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
10.4 M | 5.06 M | 6.75 M | 7.6 M | 9.24 M | 6.65 M | 9.27 M | 12.3 M | 15.3 M | 10.9 M | 12.9 M | 15.3 M | 17.2 M | 18.9 M | 8.76 M | 5.36 M | 8.76 M | 8.76 M | 7.18 M | 7.18 M | 7.18 M | 7.18 M | 7.22 M | 7.22 M | 7.22 M | 7.22 M | 6.12 M | 6.12 M | 6.12 M | 6.12 M | 491 K | 491 K | 491 K | 491 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
6.4 M | 1.13 M | 2.83 M | 3.33 M | 4.82 M | 2.36 M | 4.89 M | 8.02 M | 11.3 M | 7.13 M | 9.46 M | 11.8 M | 14 M | 16.8 M | 7.23 M | 7.23 M | 7.23 M | 7.23 M | 6.17 M | 6.17 M | 6.17 M | 6.17 M | 6.47 M | 6.47 M | 6.47 M | 6.47 M | 5.6 M | 5.6 M | 5.6 M | 5.6 M | 145 K | 145 K | 145 K | 145 K | 19.1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
8.99 M | 3.7 M | 5.66 M | 5.2 M | 6.93 M | 4.5 M | 7.2 M | 10.2 M | 13.3 M | 9.07 M | 10.8 M | 13.2 M | 15 M | 17.9 M | 7.17 M | 3.33 M | 7.17 M | 7.17 M | 4.76 M | 4.76 M | 4.76 M | 4.76 M | 6.25 M | 6.25 M | 6.25 M | 6.25 M | 5.28 M | 5.28 M | 5.28 M | 5.28 M | -894 K | -894 K | -894 K | -894 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
8.99 M | 3.7 M | 5.66 M | 5.2 M | 6.93 M | 4.5 M | 7.2 M | 10.2 M | 13.3 M | 9.07 M | 10.8 M | 13.2 M | 15 M | 17.9 M | 7.17 M | 7.17 M | 7.17 M | 7.17 M | 4.76 M | 4.76 M | 4.76 M | 4.76 M | 6.25 M | 6.25 M | 6.25 M | 6.25 M | 5.28 M | 5.28 M | 5.28 M | 5.28 M | -894 K | -894 K | -894 K | -894 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency